161 related articles for article (PubMed ID: 7605853)
1. Prescribing of antacids and ulcer-healing drugs in primary care in the north of England.
Roberts SJ; Bateman DN
Aliment Pharmacol Ther; 1995 Apr; 9(2):137-43. PubMed ID: 7605853
[TBL] [Abstract][Full Text] [Related]
2. Antacid (A02A) and antiulcer (A02B) drug prescription patterns: predicting factors, dosage and treatment duration.
Morales Suárez-Varela MM; Pérez-Benajas MA; Girbes Pelechano VJ; Llopis-González A
Eur J Epidemiol; 1998 Jun; 14(4):363-72. PubMed ID: 9690755
[TBL] [Abstract][Full Text] [Related]
3. Impact of the reclassification of omeprazole on the prescribing and sales of ulcer healing drugs.
Dhippayom T; Walker R
Pharm World Sci; 2006 Aug; 28(4):194-8. PubMed ID: 17066243
[TBL] [Abstract][Full Text] [Related]
4. Survey of prescriptions for peptic ulcer drugs (ACT class AOB2) in Iceland.
Thors H; Sigurdsson H; Oddsson E; Thjodleifsson B
Scand J Gastroenterol; 1994 Nov; 29(11):988-94. PubMed ID: 7871379
[TBL] [Abstract][Full Text] [Related]
5. Which patients are prescribed inhaled anti-asthma drugs?
Roberts SJ; Bateman DN
Thorax; 1994 Nov; 49(11):1090-5. PubMed ID: 7831622
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic investigation rates and use of prescription and non-prescription medications amongst dyspeptics: a population-based study of 2300 Australians.
Westbrook JI; Talley NJ
Aliment Pharmacol Ther; 2003 May; 17(9):1171-8. PubMed ID: 12752354
[TBL] [Abstract][Full Text] [Related]
7. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
8. [Acid-related disease in the population of two Norwegian municipalities--diagnosis and drug therapy].
Vetvik K; Straand J
Tidsskr Nor Laegeforen; 2001 Feb; 121(5):557-62. PubMed ID: 11301609
[TBL] [Abstract][Full Text] [Related]
9. Does acid suppression by antacids and H2 receptor antagonists increase the incidence of atrophic gastritis in patients with or without H. pylori gastritis?
Carter M; Katz DL; Haque S; DeLuca VA
J Clin Gastroenterol; 1999 Sep; 29(2):183-7. PubMed ID: 10478882
[TBL] [Abstract][Full Text] [Related]
10. The Diagnosis and Therapy Survey October 1978-March 1983, health care consumption and current drug therapy in Sweden with respect to the clinical diagnosis of gastritis.
Lööf L; Adami HO; Agenäs I; Gustavsson S; Nyberg A; Nyrén O
Scand J Gastroenterol Suppl; 1985; 109():35-9. PubMed ID: 3860921
[TBL] [Abstract][Full Text] [Related]
11. Trends in prescribing H2-receptor antagonists and proton pump inhibitors in primary care.
Martin RM; Lim AG; Kerry SM; Hilton SR
Aliment Pharmacol Ther; 1998 Aug; 12(8):797-805. PubMed ID: 9726394
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists.
Fusamoto H; Kawano S; Tsuji S; Oshita M; Nagano K; Ohmae A; Sawaoka H; Nagai Y; Kasahara A; Sugimoto T; Kamada T
Hepatogastroenterology; 1996; 43(7):169-73. PubMed ID: 8682457
[TBL] [Abstract][Full Text] [Related]
13. Application of a data-mining technique to analyze coprescription patterns for antacids in Taiwan.
Chen TJ; Chou LF; Hwang SJ
Clin Ther; 2003 Sep; 25(9):2453-63. PubMed ID: 14604744
[TBL] [Abstract][Full Text] [Related]
14. Age, sex, and temporary resident originated prescribing units (ASTRO-PUs): new weightings for analysing prescribing of general practices in England.
Roberts SJ; Harris CM
BMJ; 1993 Aug; 307(6902):485-8. PubMed ID: 8305014
[TBL] [Abstract][Full Text] [Related]
15. Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects.
Higham J; Kang JY; Majeed A
Gut; 2002 Apr; 50(4):460-4. PubMed ID: 11889062
[TBL] [Abstract][Full Text] [Related]
16. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
[TBL] [Abstract][Full Text] [Related]
17. Antacids. Indications and limitations.
Ching CK; Lam SK
Drugs; 1994 Feb; 47(2):305-17. PubMed ID: 7512903
[TBL] [Abstract][Full Text] [Related]
18. Medical therapy of peptic ulcer disease.
McQuaid KR; Isenberg JI
Surg Clin North Am; 1992 Apr; 72(2):285-316. PubMed ID: 1347960
[TBL] [Abstract][Full Text] [Related]
19. Medical treatment of peptic ulcers.
Deveney CW; Deveney KE
Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
[TBL] [Abstract][Full Text] [Related]
20. Prescription of acid-suppressing drugs in relation to endoscopic diagnosis: a record-linkage study.
Prach AT; McGilchrist MM; Murray FE; Johnston DA; MacDonald TM
Aliment Pharmacol Ther; 1999 Mar; 13(3):397-405. PubMed ID: 10102974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
